Android app Apple app link

Madrigal Pharmaceuticals, Inc. (MDGL) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$514.06

$42.16 (-7.58%)
Last update: 02:57 AM EST
Day's range
$511.03
Day's range
$555.1

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
01/06/2026 Wolfe Research Andy Chen $579.00 $588.40   -1.6%
12/19/2025 Piper Sandler Yasmeen Rahimi $900.00 $588.81   52.85%
11/20/2025 Oppenheimer Jay Olson $650.00 $568.02   14.43%
10/10/2025 Oppenheimer Jay Olson $590.00 $428.30   37.75%
05/02/2025 Canaccord Genuity Edward Nash $420.00 $315.48   33.13%
05/29/2024 Piper Sandler Yasmeen Rahimi $336.00 $221.76   51.52%
05/09/2024 H.C. Wainwright Ed Acre $390.00 $208.04   87.46%
03/19/2024 Evercore ISI Liisa Bayko $405.00 $265.68   52.44%
03/15/2024 UBS Eliana Merle $410.00 $270.37   51.64%
03/15/2024 Jefferies Akash Tewari $400.00 $270.37   47.95%
03/15/2024 H.C. Wainwright Ed Acre $425.00 $270.37   57.19%
03/14/2024 JMP Securities Jonathan Wolleben $397.00 $270.37   46.84%
03/14/2024 B.Riley Financial Mayank Mamtani $270.00 $270.37   -0.14%
08/05/2021 BMO Capital Matthew Luchini $111.00 $90.95   22.05%
05/19/2021 Goldman Sachs Andrea Tan $195.00 $129.77   50.27%
05/05/2021 Wells Fargo Derek Archila $130.00 $126.71   2.6%

Madrigal Pharmaceuticals, Inc. FAQ's

Madrigal Pharmaceuticals, Inc. has been rated by research analysts at Wolfe Research, Piper Sandler, UBS, H.C. Wainwright, Oppenheimer, Truist Financial in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.